US6419931B1
(en)
*
|
1991-08-26 |
2002-07-16 |
Epimmune Inc. |
Compositions and methods for eliciting CTL immunity
|
US7252829B1
(en)
*
|
1998-06-17 |
2007-08-07 |
Idm Pharma, Inc. |
HLA binding peptides and their uses
|
US7611713B2
(en)
*
|
1993-03-05 |
2009-11-03 |
Pharmexa Inc. |
Inducing cellular immune responses to hepatitis B virus using peptide compositions
|
US20110097352A9
(en)
*
|
1992-01-29 |
2011-04-28 |
Pharmexa Inc. |
Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions
|
US20030152580A1
(en)
*
|
1994-07-21 |
2003-08-14 |
Alessandro Sette |
Hla binding peptides and their uses
|
IL105554A
(en)
*
|
1992-05-05 |
1999-08-17 |
Univ Leiden |
Peptides of human papillomavirus for use in preparations elicit a human T cell response
|
US9340577B2
(en)
*
|
1992-08-07 |
2016-05-17 |
Epimmune Inc. |
HLA binding motifs and peptides and their uses
|
US9266930B1
(en)
*
|
1993-03-05 |
2016-02-23 |
Epimmune Inc. |
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions
|
US6410022B1
(en)
*
|
1995-05-01 |
2002-06-25 |
Avant Immunotherapeutics, Inc. |
Modulation of cholesteryl ester transfer protein (CETP) activity
|
US5853719A
(en)
|
1996-04-30 |
1998-12-29 |
Duke University |
Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA
|
US7888100B2
(en)
*
|
1996-10-03 |
2011-02-15 |
Memorial Sloan-Kettering Cancer Research |
Isolated nucleic acid molecules which encode immunogenic portions of NY-ESO-1 protein
|
US6465251B1
(en)
*
|
1996-11-13 |
2002-10-15 |
Dana-Farber Cancer Institute, Inc. |
Method of promoting b-cell proliferation and activation with CD40 ligand and cyclosporin
|
US6087441A
(en)
*
|
1997-02-05 |
2000-07-11 |
Ludwig Institute For Cancer Research |
Structurally modified peptides that are resistant to peptidase degradation
|
US6326200B1
(en)
*
|
1997-06-23 |
2001-12-04 |
Ludwig Institute For Cancer Research |
Isolated nona-and decapeptides which bind to HLA molecules, and the use thereof
|
US6821516B1
(en)
*
|
1997-07-18 |
2004-11-23 |
I.D.M. Immuno-Designed Molecules |
Macrophages, process for preparing the same and their use as active substances of pharmaceutical compositions
|
US6548296B1
(en)
|
1997-07-23 |
2003-04-15 |
Roche Diagnostics Gmbh |
Methods for identifying human cell lines useful for endogenous gene activation, isolated human lines identified thereby, and uses thereof
|
US5891432A
(en)
*
|
1997-07-29 |
1999-04-06 |
The Immune Response Corporation |
Membrane-bound cytokine compositions comprising GM=CSF and methods of modulating an immune response using same
|
US5965535A
(en)
*
|
1997-09-12 |
1999-10-12 |
Ludwig Institute For Cancer Research |
Mage-3 peptides presented by HLA class II molecules
|
US6432707B1
(en)
|
1997-12-24 |
2002-08-13 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of breast cancer
|
AU2010699A
(en)
*
|
1997-12-24 |
1999-07-19 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of breast cancer and methods for theiruse
|
US6410507B1
(en)
*
|
1997-12-24 |
2002-06-25 |
Corixa Corporation |
Compounds for immunotherapy and diagnosis of breast cancer and methods for their use
|
US6379951B1
(en)
|
1997-12-24 |
2002-04-30 |
Corixa Corporation |
Compounds for immunotherapy of breast cancer and methods for their use
|
US6080399A
(en)
*
|
1998-04-23 |
2000-06-27 |
Arch Development Corporation |
Vaccine adjuvants for immunotherapy of melanoma
|
AU4078599A
(en)
*
|
1998-05-13 |
1999-11-29 |
Epimmune, Inc. |
Expression vectors for stimulating an immune response and methods of using the same
|
US7521197B2
(en)
*
|
1998-06-05 |
2009-04-21 |
Alexis Biotech Limited |
Method for producing cytotoxic T-cells
|
US20020051783A1
(en)
*
|
1998-06-05 |
2002-05-02 |
Savage Philip Michael |
Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means
|
US7264965B2
(en)
*
|
1998-06-05 |
2007-09-04 |
Alexis Biotech Limited |
Method for producing or enhancing a T-cell response against a target cell using a complex comprising an HLA class I molecule and an attaching means
|
IL125608A0
(en)
|
1998-07-30 |
1999-03-12 |
Yeda Res & Dev |
Tumor associated antigen peptides and use of same as anti-tumor vaccines
|
DE69936868T2
(de)
|
1998-09-01 |
2008-05-15 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Page-4, ein gage-ähnliches gen auf dem x-chromosom das von neoplastischer prostata, testis und uterus exprimiert wird, und dessen anwendungen
|
US6468758B1
(en)
|
1998-09-23 |
2002-10-22 |
Corixa Corporation |
Compositions and methods for ovarian cancer therapy and diagnosis
|
US20070020327A1
(en)
*
|
1998-11-10 |
2007-01-25 |
John Fikes |
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
|
EP1161147A4
(de)
*
|
1998-12-24 |
2002-07-24 |
New York Medical College |
Peptid-mimetika zur behandlung von krankheiten
|
IT1309584B1
(it)
*
|
1999-02-26 |
2002-01-24 |
San Raffaele Centro Fond |
Peptidi immunogenici derivati da mage-3 presentati da mhc di classeii e loro uso.
|
US6190670B1
(en)
*
|
1999-04-12 |
2001-02-20 |
Immtech International Inc. |
Use of mCRP to enhance immune responses
|
IT1312568B1
(it)
*
|
1999-05-21 |
2002-04-22 |
Genera Spa |
Peptidi immunogenici e loro uso.
|
CA2382774A1
(en)
*
|
1999-05-25 |
2000-11-30 |
Human Genome Sciences, Inc. |
Meth1 and meth2 polynucleotides and polypeptides
|
DE19925199A1
(de)
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
DE19925235A1
(de)
|
1999-06-01 |
2000-12-07 |
Medigene Ag |
Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie
|
CA2377525A1
(en)
*
|
1999-07-19 |
2001-03-29 |
Epimmune, Inc. |
Inducing cellular immune responses to hepatitis c virus using peptide and nucleic acid compositions
|
WO2001023577A2
(en)
*
|
1999-09-30 |
2001-04-05 |
Institut Pasteur |
Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis b virus sequences
|
US6897288B1
(en)
*
|
1999-10-19 |
2005-05-24 |
Ludwig Institute For Cancer Research |
Mage-A12 antigenic peptides and uses thereof
|
DK1230268T3
(da)
*
|
1999-11-18 |
2010-02-08 |
Epimmune Inc |
Heteroklitiske analoger af klasse I-epitoper
|
EP1248800A2
(de)
|
1999-11-30 |
2002-10-16 |
Corixa Corporation |
Kompositionen und methoden zur therapie und diagnose von brustkrebs
|
US7026443B1
(en)
*
|
1999-12-10 |
2006-04-11 |
Epimmune Inc. |
Inducing cellular immune responses to human Papillomavirus using peptide and nucleic acid compositions
|
CA2393339A1
(en)
*
|
1999-12-10 |
2001-06-14 |
Epimmune Inc. |
Inducing cellular immune responses to mage2/3 using peptide and nucleic acid compositions
|
JP2003516131A
(ja)
*
|
1999-12-10 |
2003-05-13 |
エピミューン, インコーポレイテッド |
ペプチドおよび核酸組成物を使用する、p53に対する細胞性免疫応答の誘導
|
US20070098776A1
(en)
*
|
1999-12-13 |
2007-05-03 |
Fikes John D |
HLA class I A2 tumor associated antigen peptides and vaccine compositions
|
WO2001045728A2
(en)
*
|
1999-12-21 |
2001-06-28 |
Epimmune Inc. |
Inducing cellular immune responses to prostate cancer antigens using peptide and nucleic acid compositions
|
US20040248113A1
(en)
*
|
1999-12-28 |
2004-12-09 |
Alessandro Sette |
Method and system for optimizing multi-epitope nucleic acid constructs and peptides encoded thereby
|
US7462354B2
(en)
*
|
1999-12-28 |
2008-12-09 |
Pharmexa Inc. |
Method and system for optimizing minigenes and peptides encoded thereby
|
EP1118860A1
(de)
*
|
2000-01-21 |
2001-07-25 |
Rijksuniversiteit te Leiden |
Verfahren zur Auswahl und zur Herstellung von T-Zellen-Peptidepitopen sowie darauf basierten Impfstoffen
|
US7851212B2
(en)
*
|
2000-05-10 |
2010-12-14 |
Sanofi Pasteur Limited |
Immunogenic polypeptides encoded by MAGE minigenes and uses thereof
|
EP1322288A4
(de)
*
|
2000-09-08 |
2005-02-23 |
Epimmune Inc |
Auslösung von zellulären immunantworten auf das hepatitis-b-virus mit peptid- und nucleinsäurezusammensetzungen
|
JP4194365B2
(ja)
|
2000-10-31 |
2008-12-10 |
エムジーアイ ファーマ バイオロジックス インコーポレイテッド |
Cyp1b1核酸および使用の方法
|
US20040121946A9
(en)
*
|
2000-12-11 |
2004-06-24 |
John Fikes |
Inducing cellular immune responses to her2/neu using peptide and nucleic acid compositions
|
CA2430896A1
(en)
*
|
2000-12-13 |
2002-06-20 |
Argonex Pharmaceuticals, Inc. |
Mhc class i associated peptides for prevention and treatment of tuberculosis
|
US20040071671A1
(en)
*
|
2001-02-20 |
2004-04-15 |
Leturcq Didier J. |
Cell therapy method for the treatment of tumors
|
DK2016930T3
(en)
*
|
2001-02-20 |
2014-12-08 |
Janssen Pharmaceuticals Inc |
CD8 cell suspension for use in the treatment of melanomas
|
AU2002305138A1
(en)
|
2001-04-09 |
2002-10-21 |
Mayo Foundation For Medical Education And Research |
Methods and materials for cancer treatment
|
WO2002092120A1
(en)
*
|
2001-05-15 |
2002-11-21 |
Ludwig Institute For Cancer Research |
Structurally modified peptides and uses thereof
|
US20060222656A1
(en)
*
|
2005-04-01 |
2006-10-05 |
University Of Maryland, Baltimore |
MAGE-A3/HPV 16 peptide vaccines for head and neck cancer
|
AU2002322009A1
(en)
*
|
2001-05-18 |
2002-12-03 |
Mayo Foundation For Medical Education And Research |
Chimeric antigen-specific t cell-activating polypeptides
|
WO2002097044A2
(en)
*
|
2001-05-25 |
2002-12-05 |
Thomas Jefferson University |
Alternative splice forms of proteins as basis for multiple therapeutic modalities
|
US20030049253A1
(en)
*
|
2001-08-08 |
2003-03-13 |
Li Frank Q. |
Polymeric conjugates for delivery of MHC-recognized epitopes via peptide vaccines
|
IL145926A0
(en)
|
2001-10-15 |
2002-07-25 |
Mor Research Applic Ltd |
Peptide epitopes of mimotopes useful in immunomodulation
|
US7422751B2
(en)
*
|
2002-06-14 |
2008-09-09 |
Mayo Foundation For Medical Education And Research |
Epstein-barr-virus-specific immunization
|
MXPA05003049A
(es)
|
2002-09-19 |
2005-11-17 |
Us Gov Health & Human Serv |
Polipeptidos de phlebotomus ariasi, polipeptidos de phlebotomus perniciosus y metodos de uso.
|
EP1572968B1
(de)
|
2002-10-29 |
2009-04-22 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Lutzomyia longipalpis-polypeptide und verwendungsverfahren
|
WO2005012502A2
(en)
*
|
2003-03-28 |
2005-02-10 |
Idm Pharma, Inc. |
Methods of identifying optimal variants of peptide epitopes
|
US20050249743A1
(en)
*
|
2004-01-12 |
2005-11-10 |
Thierry Boon-Falleur |
Isolated peptides which bind to HLA-A24 molecules and uses thereof
|
US20060073159A1
(en)
*
|
2004-05-25 |
2006-04-06 |
The Trustees Of The University Of Pennsylvania |
Human anti-cancer immunotherapy
|
JP2008509654A
(ja)
*
|
2004-06-01 |
2008-04-03 |
イノジェネティックス・ナムローゼ・フェンノートシャップ |
C型肝炎ウイルスに対するctlおよび/またはhtl応答を誘導するためのペプチド
|
AU2005265182B2
(en)
*
|
2004-06-17 |
2012-06-21 |
Mannkind Corporation |
Epitope analogs
|
DE102004049223A1
(de)
*
|
2004-10-08 |
2006-04-20 |
Johannes-Gutenberg-Universität Mainz |
Zubereitung zum Impfen, Impfverfahren und Verwendung einer Impf-Zubereitung
|
US8124397B2
(en)
*
|
2005-08-08 |
2012-02-28 |
Oregon Health & Science University |
Inactivating pathogens with oxidizing agents for vaccine production
|
EP2397854B1
(de)
|
2006-03-14 |
2014-06-04 |
Oregon Health and Science University |
Methoden zur Detektion einer Mycobakterium tuberculosis Infektion
|
US20090220534A1
(en)
*
|
2006-03-16 |
2009-09-03 |
Leiden University Medical Center |
Methods for identifying t-cell epitopes associated with impaired peptide processing and applications of the identified epitopes
|
WO2008053573A1
(fr)
|
2006-10-30 |
2008-05-08 |
National University Corporation Hokkaido University |
Remède pour néoplasme malin
|
DK2918598T3
(en)
|
2007-02-28 |
2019-04-29 |
The Govt Of U S A As Represented By The Secretary Of The Dept Of Health And Human Services |
Brachyury polypeptides and methods of use
|
US20090117123A1
(en)
*
|
2007-11-02 |
2009-05-07 |
National Health Research Institutes |
Immunopeptides of hpv e6 and e7 proteins
|
WO2009123188A1
(ja)
|
2008-03-31 |
2009-10-08 |
株式会社バイオイミュランス |
MHCクラスII分子に提示されるサーバイビン(Survivin)の部分ペプチドとその利用法
|
WO2010088393A2
(en)
*
|
2009-01-28 |
2010-08-05 |
Antigen Express, Inc. |
Li-kay hybrid peptides that modulate the immune response to influenza
|
US9249187B2
(en)
|
2009-01-28 |
2016-02-02 |
Epimmune Inc. |
Pan-DR binding polypeptides and uses thereof
|
US8664183B2
(en)
|
2009-02-27 |
2014-03-04 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
SPANX-B polypeptides and their use
|
CN102782138A
(zh)
|
2009-10-07 |
2012-11-14 |
Uvic工业合伙公司 |
包含热敏性转基因的疫苗
|
EP3263124A1
(de)
|
2009-11-20 |
2018-01-03 |
Oregon Health&Science University |
Verfahren zum hervorrufen einer immunantwort auf tuberkulose
|
WO2011112599A2
(en)
|
2010-03-12 |
2011-09-15 |
The United States Of America, As Represented By The Secretary. Department Of Health & Human Services |
Immunogenic pote peptides and methods of use
|
US8883171B2
(en)
|
2010-09-14 |
2014-11-11 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Computationally optimized broadly reactive antigens for influenza
|
WO2012142164A1
(en)
|
2011-04-12 |
2012-10-18 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies that bind insulin-like growth factor (igf) i and ii
|
JP6113155B2
(ja)
|
2011-06-20 |
2017-04-12 |
ユニバーシティ オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケイション |
計算で最適化した広い反応性を示すh1n1インフルエンザの抗原
|
ES2626013T3
(es)
|
2011-09-06 |
2017-07-21 |
Novo Nordisk A/S |
Derivados de GLP-1
|
IL290105B2
(en)
|
2011-09-15 |
2024-04-01 |
Us Health |
MAGE-recognizing T cell receptors are restricted to 1HLA–A or HLA–CW7
|
WO2013119683A1
(en)
|
2012-02-07 |
2013-08-15 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for h3n2, h2n2, and b influenza viruses
|
CA2863949C
(en)
|
2012-02-13 |
2021-06-29 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Computationally optimized broadly reactive antigens for human and avian h5n1 influenza
|
WO2014043518A1
(en)
|
2012-09-14 |
2014-03-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Brachyury protein, non-poxvirus non-yeast vectors encoding brachyury protein, and their use
|
JP6758185B2
(ja)
|
2013-12-13 |
2020-09-23 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
マルチエピトープtarpペプチドワクチンおよびその使用
|
US10253075B2
(en)
|
2014-02-26 |
2019-04-09 |
tella, Inc. |
WT1 antigenic polypeptide, and anti-tumor agent containing said polypeptide
|
WO2015175361A1
(en)
*
|
2014-05-13 |
2015-11-19 |
Immunotope, Inc. |
Dengue virus specific multiple hla binding t cell epitopes for the use of universal vaccine development
|
EP3473271B1
(de)
|
2014-07-31 |
2022-07-20 |
The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services |
Humane monoklonale antikörper gegen epha4 und deren verwendung
|
EP3331554B1
(de)
|
2015-08-03 |
2022-05-11 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Brachyury-deletionsmutanten, nichthefevektoren zur codierung von brachyury-deletionsmutanten und verwendung davon
|
CN105037559B
(zh)
*
|
2015-08-17 |
2018-09-25 |
北京康爱瑞浩生物科技股份有限公司 |
治疗或预防乙肝的细胞毒性t淋巴细胞及其制备方法
|
CN109069575A
(zh)
*
|
2016-02-23 |
2018-12-21 |
毛里齐奥·扎内蒂 |
通用癌症疫苗
|
ES2929274T3
(es)
|
2016-05-10 |
2022-11-28 |
Najit Tech Inc |
Inactivación de patógenos y producción de vacunas inactivadas altamente inmunógenas utilizando un proceso de oxidación dual
|
US20180161433A1
(en)
*
|
2017-03-22 |
2018-06-14 |
Timothy Andrew Erickson |
Size tunable microbial mimetics for immunotherapy of thyroid carcinomas and solid tumors
|
JP2020518648A
(ja)
|
2017-05-08 |
2020-06-25 |
グリットストーン オンコロジー インコーポレイテッド |
アルファウイルス新生抗原ベクター
|
WO2019133853A1
(en)
*
|
2017-12-28 |
2019-07-04 |
Gritstone Oncology, Inc. |
Antigen-binding proteins targeting shared antigens
|
CN111818943A
(zh)
|
2018-01-04 |
2020-10-23 |
伊科尼克治疗公司 |
抗组织因子抗体、抗体-药物缀合物及相关方法
|
US11344614B2
(en)
|
2018-09-29 |
2022-05-31 |
Emergex Vaccines Holding Ltd. |
Pharmaceutical compositions comprising dengue virus-specific multiple HLA-binding T cell epitopes
|
CA3140019A1
(en)
|
2019-05-30 |
2020-12-03 |
Gritstone Bio, Inc. |
Modified adenoviruses
|
WO2022032196A2
(en)
|
2020-08-06 |
2022-02-10 |
Gritstone Bio, Inc. |
Multiepitope vaccine cassettes
|
FR3119325B1
(fr)
|
2021-01-29 |
2023-08-11 |
Renault Jean Yves |
Compositions liposomales orales
|